Pauls Matthew's most recent trade in Soleno Therapeutics Inc was a trade of 3,991 Common Stock done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Soleno Therapeutics Inc | Matthew Pauls | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 3,991 | 10,491 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | Matthew Pauls | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.60 per share. | 28 Mar 2025 | 5,937 | 12,437 (0%) | 0% | 4.6 | 27,310 | Common Stock |
| Soleno Therapeutics Inc | Matthew Pauls | Director | Sale of securities on an exchange or to another person at price $ 71.55 per share. | 28 Mar 2025 | 5,937 | 6,500 (0%) | 0% | 71.6 | 424,797 | Common Stock |
| Soleno Therapeutics Inc | Matthew Pauls | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 5,937 | 9,063 | - | - | Employee stock option (right to buy) | |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 900,000 | 900,000 | - | - | Stock Option (Right to Buy) | |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 400,000 | 1,683,674 (3%) | 0% | 0 | Common Stock | |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.21 per share. | 12 Dec 2024 | 92,593 | 1,591,081 (3%) | 0% | 3.2 | 297,224 | Common Stock |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 3.31 per share. | 12 Dec 2024 | 54,702 | 1,536,379 (3%) | 0% | 3.3 | 180,828 | Common Stock |
| Soleno Therapeutics Inc | Matthew Pauls | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 6,500 | 6,500 (0%) | 0% | 0 | Common Stock | |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 4.71 per share. | 28 Dec 2023 | 84,000 | 1,302,674 (2%) | 0% | 4.7 | 395,900 | Common Stock |
| Savara Inc | Pauls Matthew | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Dec 2023 | 19,000 | 1,283,674 (2%) | 0% | 0 | Common Stock | |
| Savara Inc | Pauls Matthew | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 450,000 | 1,386,674 (2%) | 0% | 0 | Common Stock | |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Savara Inc | Pauls Matthew | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.45 per share. | 14 Dec 2023 | 109,680 | 936,674 (1%) | 0% | 4.5 | 488,076 | Common Stock |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 700,000 | 700,000 | - | - | Stock Option (Right to Buy) | |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 325,000 | 1,046,354 (2%) | 0% | 0 | Common Stock | |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 400,000 | 783,672 (1%) | 0% | 0 | Common Stock | |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 350,000 | 350,000 | - | - | Stock Option (Right to Buy) | |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.06 per share. | 08 Dec 2021 | 6,500 | 383,672 (0%) | 0% | 1.1 | 6,889 | Common Stock |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 02 Dec 2021 | 10,000 | 377,172 (0%) | 0% | 1.1 | 10,954 | Common Stock |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 18 Nov 2021 | 10,000 | 355,022 (0%) | 0% | 1.1 | 11,000 | Common Stock |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 18 Nov 2021 | 10,000 | 365,022 (0%) | 0% | 1.1 | 11,100 | Common Stock |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.07 per share. | 18 Nov 2021 | 2,150 | 367,172 (0%) | 0% | 1.1 | 2,290 | Common Stock |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 17 Aug 2021 | 15,000 | 333,122 (0%) | 0% | 1.2 | 17,700 | Common Stock |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.19 per share. | 17 Aug 2021 | 11,900 | 345,022 (0%) | 0% | 1.2 | 14,166 | Common Stock |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.63 per share. | 21 May 2021 | 10,000 | 318,122 (0%) | 0% | 1.6 | 16,298 | Common Stock |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.82 per share. | 19 Apr 2021 | 27,400 | 308,122 (0%) | 0% | 1.8 | 49,871 | Common Stock |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 2.07 per share. | 22 Mar 2021 | 24,100 | 280,722 (0%) | 0% | 2.1 | 49,938 | Common Stock |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.74 per share. | 22 Feb 2021 | 28,700 | 256,622 (0%) | 0% | 1.7 | 50,038 | Common Stock |
| Savara Inc | Matthew Pauls | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2020 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) |